accounthepatitis C drug in almost a decade after studies showed it cured more patients than existing treatments. The Food and Drug Administration cleared boceprevir to treat people with chronic hepatitis C in combination with interferon-based therapy, the...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to FDA approves Merck drug
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account